Jonathan Slonin

CIK: 0001875723

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)4 (33.3%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (16.7%)

Compensation grants

Other (G, F, J, C, D, …)6 (50.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

PCRX

Pacira BioSciences, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (12 total)

PCRX
Pacira BioSciences, Inc.
Aug 17, 2026
Sale(S)
Direct
3K shares at avg. $23.23$71K
PCRX
Pacira BioSciences, Inc.
Jun 3, 2026
Tax Payment(F)
Direct
4.7K shares at avg. $22.32$106K
PCRX
Pacira BioSciences, Inc.
Mar 17, 2026
Sale(S)
Direct
3.3K shares at avg. $22.82$74K
PCRX
Pacira BioSciences, Inc.
Feb 11, 2026
Award(A)
Direct
54.5K shares-
PCRX
Pacira BioSciences, Inc.
Jan 30, 2026
Tax Payment(F)
Direct
6.2K shares at avg. $20.54$127K
PCRX
Pacira BioSciences, Inc.
Jan 2, 2026
Tax Payment(F)
Direct
381 shares at avg. $24.46$9K
PCRX
Pacira BioSciences, Inc.
Nov 17, 2025
Sale(S)
Direct
4K shares at avg. $24.09$95K
PCRX
Pacira BioSciences, Inc.
Aug 1, 2025
Tax Payment(F)
Direct
315 shares at avg. $22.07$7K
PCRX
Pacira BioSciences, Inc.
Jun 3, 2025
Tax Payment(F)
Direct
5.1K shares at avg. $26.40$134K
PCRX
Pacira BioSciences, Inc.
Feb 1, 2025
Award(A)
Direct
93.6K shares-
PCRX
Pacira BioSciences, Inc.
Jan 6, 2025
Sale(S)
Direct
879 shares at avg. $18.40$16K
PCRX
Pacira BioSciences, Inc.
Jan 2, 2025
Tax Payment(F)
Direct
371 shares at avg. $18.33$7K

		Type	Shares	Price		Ownership
Aug 17, 2026	PCRX Pacira BioSciences, Inc.	Sale(S)	3,040	$23.23	$70,619	Direct
Jun 3, 2026	PCRX Pacira BioSciences, Inc.	Tax Payment(F)	4,728	$22.32	$105,529	Direct
Mar 17, 2026	PCRX Pacira BioSciences, Inc.	Sale(S)	3,261	$22.82	$74,416	Direct
Feb 11, 2026	PCRX Pacira BioSciences, Inc.	Award(A)	54,546	-	$0	Direct
Jan 30, 2026	PCRX Pacira BioSciences, Inc.	Tax Payment(F)	6,168	$20.54	$126,691	Direct
Jan 2, 2026	PCRX Pacira BioSciences, Inc.	Tax Payment(F)	381	$24.46	$9,319	Direct
Nov 17, 2025	PCRX Pacira BioSciences, Inc.	Sale(S)	3,960	$24.09	$95,396	Direct
Aug 1, 2025	PCRX Pacira BioSciences, Inc.	Tax Payment(F)	315	$22.07	$6,952	Direct
Jun 3, 2025	PCRX Pacira BioSciences, Inc.	Tax Payment(F)	5,084	$26.40	$134,218	Direct
Feb 1, 2025	PCRX Pacira BioSciences, Inc.	Award(A)	93,600	-	-	Direct
Jan 6, 2025	PCRX Pacira BioSciences, Inc.	Sale(S)	879	$18.40	$16,174	Direct
Jan 2, 2025	PCRX Pacira BioSciences, Inc.	Tax Payment(F)	371	$18.33	$6,800	Direct

1-12 of 12 transactions

About SLONIN JONATHAN

SLONIN JONATHAN (SEC CIK 0001875723) files insider reports with the SEC as Chief Medical Officer of Pacira BioSciences, Inc. (PCRX).

Signal8 holds 11 ownership filings by SLONIN JONATHAN, all Form 4s, filed between Jan 6, 2025 and Aug 18, 2026. Those filings report 12 transactions, from Jan 2, 2025 to Aug 17, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on SLONIN JONATHAN's filings is in BRISBANE, CA.

Recent filings by SLONIN JONATHAN

Aug 17, 2026: Open-market sale of PCRX shares (Form 4, code S).
Jun 3, 2026: Tax withholding of PCRX shares (Form 4, code F).
Mar 17, 2026: Open-market sale of PCRX shares (Form 4, code S).
Feb 11, 2026: Grant or award of PCRX shares (Form 4, code A).
Jan 30, 2026: Tax withholding of PCRX shares (Form 4, code F).

Other insiders filing for Pacira BioSciences, Inc. (PCRX)

RIKER LAUREN, Senior Vice President, Finance
Hirawat Samit, Director
CHRISTIE CHRISTOPHER, Director
WIGGANS THOMAS G, Director
Young Alethia, Director
YANG MICHAEL J., Director

How to read Form 4 transaction codes